Antihypertensive Effect of Sesamin. II. Protection against Two-Kidney, One-Clip Renal Hypertension and Cardiovascular Hypertrophy

• Published in: Biological & pharmaceutical bulletin 1995/09/15, Vol.18(9), pp.1283-1285
• Main Authors: KITA, Satomi, MATSUMURA, Yasuo, MORIMOTO, Shiro, AKIMOTO, Kengo, FURUYA, Mayumi, OKA, Naomi, TANAKA, Takaharu
• Format: Article
• Language: English
• Subjects: Animals; Antihypertensive Agents - therapeutic use; cardiac hypertrophy; Cardiomegaly - prevention & control; Dioxoles - therapeutic use; hypertension; Hypertension, Renovascular - prevention & control; Lignans; Male; one-clip; Rats; Rats, Sprague-Dawley; Sesame Oil - therapeutic use; sesamin; two-kidney; vascular hypertrophy
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.18.1283

We investigated the antihypertensive effect of sesamin, a lignan from sesame oil, using two-kidney, one-clip (2K, 1C) renal hypertensive rats. After clipping the left renal artery, animals were assigned to either a normal diet group (control group) or a sesamin-containing (1% (w/w)) diet group (sesamin group). The sham-operated rats (sham group) were fed a normal diet and tap water. The systolic blood pressure of the control group increased progressively in comparison with the sham group. This 2K, 1C-induced hypertension was markedly reduced by feeding the sesamin-containing diet. The systolic blood pressure after 4 weeks was 123.60±4.01 mmHg in the sham group, 187.43±5.69 mmHg in the control group and 145.57±6.78 mmHg in the sesamin group, respectively. There were significant increases in left ventricle plus septum weight-to-body weight ratio in the control group compared with the sham group. This rise was also significantly reduced in the sesamin group. When the thoracic aorta was histochemically evaluated, the wall thickness and wall-to-lumen ratio in the control group were significantly increased, compared with the sham group, indicating that vascular hypertrophy had occurred in the control group. The sesamin diet tended to ameliorate this vascular hypertrophy, although its effect was not statistically significant. These findings suggest that sesamin is useful as prophylactic treatment to combat the development of renal hypertension and cardiac hypertrophy.